217 related articles for article (PubMed ID: 10950775)
21. Construction and virulence testing of a collagenase mutant of Clostridium perfringens.
Awad MM; Ellemor DM; Bryant AE; Matsushita O; Boyd RL; Stevens DL; Emmins JJ; Rood JI
Microb Pathog; 2000 Feb; 28(2):107-17. PubMed ID: 10644496
[TBL] [Abstract][Full Text] [Related]
22. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C.
Neeson BN; Clark GC; Atkins HS; Lingard B; Titball RW
Microb Pathog; 2007 Oct; 43(4):161-5. PubMed ID: 17604945
[TBL] [Abstract][Full Text] [Related]
23. [Rapid diagnosis in Clostridium perfringens wound infections].
Schau HP
Z Gesamte Hyg; 1989 Oct; 35(10):608-10. PubMed ID: 2559553
[TBL] [Abstract][Full Text] [Related]
24. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
[TBL] [Abstract][Full Text] [Related]
25. Opioid analgesics stop the development of clostridial gas gangrene.
Chakravorty A; Awad MM; Hiscox TJ; Cheung JK; Choo JM; Lyras D; Rood JI
J Infect Dis; 2014 Aug; 210(3):483-92. PubMed ID: 24550443
[TBL] [Abstract][Full Text] [Related]
26. Granulocyte Colony-Stimulating Factor Does Not Influence
Takehara M; Sonobe Y; Bandou H; Kobayashi K; Nagahama M
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31480318
[No Abstract] [Full Text] [Related]
27. The role of neutrophils and monocytic cells in controlling the initiation of Clostridium perfringens gas gangrene.
O'Brien DK; Therit BH; Woodman ME; Melville SB
FEMS Immunol Med Microbiol; 2007 Jun; 50(1):86-93. PubMed ID: 17428305
[TBL] [Abstract][Full Text] [Related]
28. alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.
Hsiao G; Chang CY; Shen MY; Chou DS; Tzeng SH; Chen TF; Sheu JR
J Agric Food Chem; 2005 Jun; 53(13):5179-86. PubMed ID: 15969494
[TBL] [Abstract][Full Text] [Related]
29. [Gas gangrene--case diagnosis].
Wojdat E; Kwiatek K; Zdrojewski H; Krupa L
Przegl Epidemiol; 2005; 59(4):859-63. PubMed ID: 16729427
[TBL] [Abstract][Full Text] [Related]
30. Role of alpha-toxin in Clostridium perfringens infection determined by using recombinants of C. perfringens and Bacillus subtilis.
Ninomiya M; Matsushita O; Minami J; Sakamoto H; Nakano M; Okabe A
Infect Immun; 1994 Nov; 62(11):5032-9. PubMed ID: 7927785
[TBL] [Abstract][Full Text] [Related]
31. The heptapeptide LSARLAF mediates platelet activation through phospholipase Cgamma2 independently of glycoprotein IIb-IIIa.
Pearce AC; Wonerow P; Marshall SJ; Frampton J; Gartner TK; Watson SP
Biochem J; 2004 Feb; 378(Pt 1):193-9. PubMed ID: 14558887
[TBL] [Abstract][Full Text] [Related]
32. [Metabolic effects of anaerobic gas infection toxins].
Otdel'nova NN; Chesnokova NP; Zhevak TN
Vopr Med Khim; 1990; 36(3):83-5. PubMed ID: 2382441
[TBL] [Abstract][Full Text] [Related]
33. Platelet activation after stenting with heparin-coated versus noncoated stents.
Gurbel PA; Bliden KP
Am Heart J; 2003 Oct; 146(4):E10. PubMed ID: 14564333
[TBL] [Abstract][Full Text] [Related]
34. The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation.
Ruef J; Kuehnl P; Meinertz T; Merten M
Platelets; 2008 Aug; 19(5):359-64. PubMed ID: 18791942
[TBL] [Abstract][Full Text] [Related]
35. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
36. Clostridium septicum infections in children: a case report and review of the literature.
Smith-Slatas CL; Bourque M; Salazar JC
Pediatrics; 2006 Apr; 117(4):e796-805. PubMed ID: 16567392
[TBL] [Abstract][Full Text] [Related]
37. A defined peptide that inhibits the formation of the glycoprotein IIb and IIIa complex.
Chiang TM; Zhu J
Thromb Res; 2005; 115(6):503-8. PubMed ID: 15792682
[TBL] [Abstract][Full Text] [Related]
38. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
[TBL] [Abstract][Full Text] [Related]
39. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
Tomer A
J Biol Regul Homeost Agents; 2004; 18(2):172-7. PubMed ID: 15471223
[TBL] [Abstract][Full Text] [Related]
40. Efficient platelet delta-granule release induced by [Ca2+]i elevation is modulated by GPIIbIIIa.
Gobbi G; Sponzilli I; Mirandola P; Tazzari PL; Caimi L; Cacchioli A; Matteucci A; Giuliani Piccari G; Cocco L; Vitale M
Int J Mol Med; 2006 Aug; 18(2):309-13. PubMed ID: 16820939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
